Monoclonal Antibodies for Pre- and Postexposure Prophylaxis of COVID-19: Review of the Literature
Monoclonal antibodies are laboratory-made proteins that mimic the immune system’s ability to fight off harmful microorganisms, including viruses such as Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2). The US Food and Drug Administration (FDA) and the European Medical Agency (EMA) have...
Autors principals: | , , , , , , , , |
---|---|
Format: | Article |
Idioma: | English |
Publicat: |
MDPI AG
2022-08-01
|
Col·lecció: | Pathogens |
Matèries: | |
Accés en línia: | https://www.mdpi.com/2076-0817/11/8/882 |